BE905195A - Compositions pharmaceutiques antivirales en antitumorales. - Google Patents
Compositions pharmaceutiques antivirales en antitumorales.Info
- Publication number
- BE905195A BE905195A BE0/216195A BE216993A BE905195A BE 905195 A BE905195 A BE 905195A BE 0/216195 A BE0/216195 A BE 0/216195A BE 216993 A BE216993 A BE 216993A BE 905195 A BE905195 A BE 905195A
- Authority
- BE
- Belgium
- Prior art keywords
- antiviral
- antitumor
- compound
- pharmaceutical compositions
- adjuvant
- Prior art date
Links
- 230000000259 anti-tumor effect Effects 0.000 title abstract 4
- 230000000840 anti-viral effect Effects 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002671 adjuvant Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- -1 alkali metal deoxycholate Chemical class 0.000 abstract 1
- 125000000129 anionic group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 229940009976 deoxycholate Drugs 0.000 abstract 1
- ZOOODBUHSVUZEM-UHFFFAOYSA-N ethoxymethanedithioic acid Chemical compound CCOC(S)=S ZOOODBUHSVUZEM-UHFFFAOYSA-N 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 150000008040 ionic compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 abstract 1
- 239000012991 xanthate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3527871 | 1985-08-02 | ||
| DE3620939 | 1986-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE905195A true BE905195A (fr) | 1987-01-29 |
Family
ID=25834701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/216195A BE905195A (fr) | 1985-08-02 | 1986-07-29 | Compositions pharmaceutiques antivirales en antitumorales. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4851435A (enExample) |
| JP (1) | JPH0618786B2 (enExample) |
| AU (1) | AU585380B2 (enExample) |
| BE (1) | BE905195A (enExample) |
| CA (1) | CA1295944C (enExample) |
| CH (1) | CH673224A5 (enExample) |
| DK (1) | DK369186A (enExample) |
| FR (1) | FR2591483B1 (enExample) |
| GB (1) | GB2178957B (enExample) |
| GR (1) | GR862030B (enExample) |
| IT (1) | IT1213453B (enExample) |
| LU (1) | LU86533A1 (enExample) |
| NL (1) | NL8601895A (enExample) |
| SE (1) | SE501592C2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT392906B (de) * | 1987-10-08 | 1991-07-10 | Hoffmann La Roche | Pharmazeutische praeparate zur oralen verabreichung |
| CA2010511A1 (en) * | 1989-03-01 | 1990-09-01 | Roberto L. Ceriani | Method of enhancing cancer therapy by administration of unsaturated fatty acids |
| AU4159596A (en) * | 1994-11-14 | 1996-06-06 | Ct-Holding Sa | Antiviral and antitumor pharmaceutical compositions |
| DE10117728A1 (de) * | 2001-04-09 | 2002-10-17 | Biosphings Ag | Pharmazeutische Formulierungen für Xanthogenate |
| DE10156617A1 (de) * | 2001-11-17 | 2003-05-28 | Biosphings Ag | Herstellung reiner Stereoisomere von Tricyclo[5.2.1.0··2··.··6··]-dec-9-yl-xanthogenat und Arzneimittel daraus |
| DE10343365A1 (de) * | 2003-09-17 | 2005-04-14 | Biosphings Ag | Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation |
| ES2372499T3 (es) * | 2004-05-19 | 2012-01-20 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Uso de un detergente para la eliminación no quirúrgica de grasa. |
| US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
| US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
| DE102006014390A1 (de) * | 2006-03-29 | 2007-10-04 | Biosphings Ag | Assoziate von Xanthogenaten mit Cyclodextrinen und ihre Verwendung |
| JP2010531830A (ja) * | 2007-07-03 | 2010-09-30 | ルマビタ エージー | キサントゲン酸トリシクロデカン−９−イルの立体異性体 |
| US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
| CA2827643C (en) | 2011-02-18 | 2019-05-07 | Kythera Biopharmaceuticals, Inc. | Treatment of submental fat |
| US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4020183A (en) * | 1974-12-03 | 1977-04-26 | Ortho Pharmaceutical Corporation | Nonionic surface active anti-herpes simplex viral agents |
| CA1174978A (en) * | 1980-11-26 | 1984-09-25 | Arthur Scherm | Xanthates |
| AR230264A1 (es) * | 1980-11-26 | 1984-03-01 | Merz & Co Gmbh & Co | Procedimiento para la obtencion de compuestos de xantato |
| DK315482A (da) * | 1981-07-20 | 1983-01-21 | Kimberly Clark Co | Fremgangsmaade til hindring af spredning af aandedraetsvira og middel til anvendelse ved fremgangsmaaden |
-
1986
- 1986-07-21 IT IT8621192A patent/IT1213453B/it active
- 1986-07-22 NL NL8601895A patent/NL8601895A/nl not_active Application Discontinuation
- 1986-07-23 CH CH2960/86A patent/CH673224A5/de not_active IP Right Cessation
- 1986-07-29 BE BE0/216195A patent/BE905195A/fr not_active IP Right Cessation
- 1986-07-29 AU AU60648/86A patent/AU585380B2/en not_active Ceased
- 1986-07-30 LU LU86533A patent/LU86533A1/fr unknown
- 1986-07-30 CA CA000515025A patent/CA1295944C/en not_active Expired - Fee Related
- 1986-07-31 GR GR862030A patent/GR862030B/el unknown
- 1986-08-01 JP JP61180216A patent/JPH0618786B2/ja not_active Expired - Lifetime
- 1986-08-01 US US06/892,346 patent/US4851435A/en not_active Expired - Lifetime
- 1986-08-01 FR FR868611220A patent/FR2591483B1/fr not_active Expired - Fee Related
- 1986-08-01 GB GB8618820A patent/GB2178957B/en not_active Expired
- 1986-08-01 SE SE8603284A patent/SE501592C2/sv unknown
- 1986-08-01 DK DK369186A patent/DK369186A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU585380B2 (en) | 1989-06-15 |
| DK369186D0 (da) | 1986-08-01 |
| GR862030B (en) | 1986-12-24 |
| GB2178957A (en) | 1987-02-25 |
| FR2591483B1 (fr) | 1990-08-10 |
| SE8603284L (sv) | 1987-02-03 |
| CH673224A5 (enExample) | 1990-02-28 |
| AU6064886A (en) | 1987-02-05 |
| JPH0618786B2 (ja) | 1994-03-16 |
| CA1295944C (en) | 1992-02-18 |
| FR2591483A1 (fr) | 1987-06-19 |
| IT8621192A0 (it) | 1986-07-21 |
| NL8601895A (nl) | 1987-03-02 |
| DK369186A (da) | 1987-02-03 |
| GB8618820D0 (en) | 1986-09-10 |
| IT1213453B (it) | 1989-12-20 |
| SE8603284D0 (sv) | 1986-08-01 |
| GB2178957B (en) | 1989-12-28 |
| JPS6259223A (ja) | 1987-03-14 |
| SE501592C2 (sv) | 1995-03-20 |
| LU86533A1 (fr) | 1988-02-02 |
| US4851435A (en) | 1989-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1163001B (it) | Procedimento per la preparazione di 4' epidaunorubicina 3', 4' diepidaunorubicina e corrispondenti analoghi della doxorubicina | |
| EP0429430A3 (en) | Expectorants comprising n-acetylneuraminic acid | |
| FR2343449A1 (fr) | Ferrure tournante, notamment pour regler l'angle d'inclinaison de dossiers de siege | |
| SE8603284L (sv) | Farmaceutisk komposition | |
| EP0221728A3 (en) | Monosaccharide containing wound healing preparation | |
| IT8567298A0 (it) | Procedimento per la preparazione di 14 idrossi n etossicarbonil norco deinone | |
| AR247404A1 (es) | Composicion peptidica de uso exclusivo para el diagnostico de la enfermedad de la malaria y procedimiento de sintesis de dicha composicion peptidica | |
| IT7969279A0 (it) | 4 1 benzossazepine loro tia analoghi e procedimento per la loro preparazione | |
| ES8707737A1 (es) | Procedimiento para la obtencion de una 9 l 11 l epoxiesteroide | |
| OA08406A (fr) | Préparation de combinaison pour le traitement de la malaria. | |
| EP0166876A3 (en) | 7-oxabicycloheptane substituted prostaglandin analogs | |
| BE867634A (fr) | Composes de la serie des pregnanes avec une fonction oxygene en position 19, procede de preparation et preparations pharmaceutiques qui contiennent ces composes | |
| IT1099359B (it) | Analoghi della somatostatina e procedimento per l' loro preparazione | |
| FR2353543B1 (fr) | Analogues de 5,6-dihydro-prostacycline et leur preparation | |
| DE3370839D1 (en) | Treatment of fibrous substrates, such as carpet with fluorochemical | |
| FR2531952B1 (fr) | Analogues a forte activite gonadotrope du facteur liberant l'hormone luteinisante et l'hormone folliculostimulante et leur procede de preparation | |
| EP0193202A3 (en) | Omega-perfluoroalkyl-alpha-olefin polymers | |
| GB2001636A (en) | Prostaglandin amides | |
| IE45829L (en) | Yarn processing | |
| JPS5424588A (en) | X-ray diagnosis unit | |
| FR2361392A1 (fr) | Nouveaux 2,2-diaryl-3-(1-aza-2-bicyclo(2.2.2)octyl)propionamides utiles notamment comme agents antidiarrheiques et leur procede de preparation | |
| JPS51137897A (en) | Wiring duct and its preparation method | |
| JPS5422348A (en) | Lower cycloalkyl-substituted benzene derivatives,their preparation, and pharmaceutical compsition | |
| IT1102595B (it) | Benzomorfani sostitutti dotati di proprieta' farmacologiche e procedimento per la loro preparazione | |
| Kulczycky | The tubular systems of muscle: an electron microscope study of the effects of the hypertonic solutions and the penetration of peroxidase. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: S.A. CT-HOLDING Effective date: 19970731 |